Literature DB >> 7822279

The transforming receptor tyrosine kinase, Axl, is post-translationally regulated by proteolytic cleavage.

J P O'Bryan1, Y W Fridell, R Koski, B Varnum, E T Liu.   

Abstract

Several receptor tyrosine kinases generate soluble ligand binding domains either by differential splicing resulting in a truncated RNA transcript, or by proteolytic cleavage. Although the exact role in vivo of these soluble extracellular domains is unclear, proteolysis may function to down-regulate the receptor, and soluble extracellular domains (ECD) may compete with the intact receptor binding to ligand. Axl is a member of a new class of receptor tyrosine kinases characterized by an ECD resembling cell adhesion molecules and unique sequences in the kinase domain. In addition, Axl is transforming in both fibroblast and hematopoietic cells, and appears to be involved in mesenchymal development. We now find that Axl is post-translationally processed by cleavage in a 14 amino acid region immediately NH2-terminal to the transmembrane domain resulting in a soluble ECD and a membrane bound kinase domain. The sequence of this putative cleavage site shares no homology with recognition sites of known proteases. Characterization of this proteolytic processing shows that it does not require protein synthesis or transport but is augmented by phorbol ester treatment. Since the cleavage of Axl enhances turnover of the kinase on the cell surface, we suggest that proteolytic processing down-regulates Axl kinase activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7822279     DOI: 10.1074/jbc.270.2.551

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  68 in total

Review 1.  The role of TAM family receptors and ligands in the nervous system: From development to pathobiology.

Authors:  Bridget Shafit-Zagardo; Ross C Gruber; Juwen C DuBois
Journal:  Pharmacol Ther       Date:  2018-03-04       Impact factor: 12.310

2.  Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway.

Authors:  M Jeffers; G A Taylor; K M Weidner; S Omura; G F Vande Woude
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

Review 3.  TAM receptor signaling in immune homeostasis.

Authors:  Carla V Rothlin; Eugenio A Carrera-Silva; Lidia Bosurgi; Sourav Ghosh
Journal:  Annu Rev Immunol       Date:  2015-01-14       Impact factor: 28.527

4.  A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation.

Authors:  Susan Sather; Karla D Kenyon; Jerry B Lefkowitz; Xiayuan Liang; Brian C Varnum; Peter M Henson; Douglas K Graham
Journal:  Blood       Date:  2006-10-17       Impact factor: 22.113

5.  Imaging Axl expression in pancreatic and prostate cancer xenografts.

Authors:  Sridhar Nimmagadda; Mrudula Pullambhatla; Ala Lisok; Chaoxin Hu; Anirban Maitra; Martin G Pomper
Journal:  Biochem Biophys Res Commun       Date:  2013-12-11       Impact factor: 3.575

6.  Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival.

Authors:  Peter Vajkoczy; Pjotr Knyazev; Andrea Kunkel; Hans-Holger Capelle; Sandra Behrndt; Hendrik von Tengg-Kobligk; Fabian Kiessling; Uta Eichelsbacher; Marco Essig; Tracy-Ann Read; Ralf Erber; Axel Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

7.  Module network inference from a cancer gene expression data set identifies microRNA regulated modules.

Authors:  Eric Bonnet; Marianthi Tatari; Anagha Joshi; Tom Michoel; Kathleen Marchal; Geert Berx; Yves Van de Peer
Journal:  PLoS One       Date:  2010-04-14       Impact factor: 3.240

8.  AXL mediates TRAIL resistance in esophageal adenocarcinoma.

Authors:  Jun Hong; Abbes Belkhiri
Journal:  Neoplasia       Date:  2013-03       Impact factor: 5.715

9.  Axl, Ferritin, Insulin-Like Growth Factor Binding Protein 2, and Tumor Necrosis Factor Receptor Type II as Biomarkers in Systemic Lupus Erythematosus.

Authors:  Chi Chiu Mok; Hui Hua Ding; Marwa Kharboutli; Chandra Mohan
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-07-28       Impact factor: 4.794

10.  Gas6 and the receptor tyrosine kinase Axl in clear cell renal cell carcinoma.

Authors:  Anna Gustafsson; Anna-Karin Boström; Börje Ljungberg; Håkan Axelson; Björn Dahlbäck
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.